Skip to content
Screener

Contineum Therapeutics, Inc. CTNM Q2 2026 earnings

Reported July 30, 2026 · After market close

EPS-$0.40Beat by $0.05
EPS estimate-$0.45

Next report

Oct 29, 2026 (in a month)
Revenue estimate$5.7M
EPS estimate-$0.45

FAQ

When did Contineum Therapeutics, Inc. report Q2 2026 earnings?
Contineum Therapeutics, Inc. (CTNM) reported Q2 2026 earnings on July 30, 2026 after market close.
What were Contineum Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Contineum Therapeutics, Inc. reported eps of $-0.40 for Q2 2026.
Did Contineum Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.45 by $0.05.
How did Contineum Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 35.5% from $-0.62.
Where can I find Contineum Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-051051) and the 10-Q periodic report (0001628280-26-051054) directly on SEC EDGAR. The filing index links above go to sec.gov.